New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Investigating the role of fatty acids in cancer cell survival

Investigating the role of fatty acids in cancer cell survival

by Melissa Rohman,Northwestern UniversityIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous ep
Oncology February 18,2024
Investigating the role of fatty acids in cancer cell survival

Investigating the role of fatty acids in cancer cell survival

by Melissa Rohman,Northwestern UniversityIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous ep
Oncology February 18,2024
Researchers shed light on signaling pathway responsible for head and neck cancers

Researchers shed light on signaling pathway responsible for head and neck cancers

by Gina DiGravio,Boston University School of MedicineCausal Inference Models of Interactions Between Pathways/Cell States in Head and Neck Cancer scRNAseq Data. A. Causal inference graphs indica
Oncology February 18,2024
Researchers shed light on signaling pathway responsible for head and neck cancers

Researchers shed light on signaling pathway responsible for head and neck cancers

by Gina DiGravio,Boston University School of MedicineCausal Inference Models of Interactions Between Pathways/Cell States in Head and Neck Cancer scRNAseq Data. A. Causal inference graphs indica
Oncology February 18,2024
Cervical cancer burden remains high in many countries; scale-up needed to meet 2030 elimination target

Cervical cancer burden remains high in many countries; scale-up needed to meet 2030 elimination target

by LancetHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress to invasive cance
Oncology February 18,2024
Cervical cancer burden remains high in many countries; scale-up needed to meet 2030 elimination target

Cervical cancer burden remains high in many countries; scale-up needed to meet 2030 elimination target

by LancetHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress to invasive cance
Oncology February 18,2024
Researchers discover connection between stress-activated signaling and immune cell evasion in melanoma

Researchers discover connection between stress-activated signaling and immune cell evasion in melanoma

by H. Lee Moffitt Cancer Center & Research InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.08.016Anti-cancer immune cells are critical to inhibiti
Oncology February 18,2024
Researchers discover connection between stress-activated signaling and immune cell evasion in melanoma

Researchers discover connection between stress-activated signaling and immune cell evasion in melanoma

by H. Lee Moffitt Cancer Center & Research InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.08.016Anti-cancer immune cells are critical to inhibiti
Oncology February 18,2024
Aggressive surgery increases survival with low-grade brain tumors: Study

Aggressive surgery increases survival with low-grade brain tumors: Study

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainThe transition of a low-grade, slow growing brain tumor to a lethal one can be delayed if neurosurgeons remove as much
Oncology February 18,2024
Aggressive surgery increases survival with low-grade brain tumors: Study

Aggressive surgery increases survival with low-grade brain tumors: Study

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainThe transition of a low-grade, slow growing brain tumor to a lethal one can be delayed if neurosurgeons remove as much
Oncology February 18,2024
Study finds Black patients wait longer for uterine cancer testing, diagnosis

Study finds Black patients wait longer for uterine cancer testing, diagnosis

by Mallory Locklear,Yale UniversityCredit: Unsplash/CC0 Public DomainEarly diagnosis of uterine cancer is known to improve a patient's chances for survival, but previous research has found t
Oncology February 18,2024
Study finds Black patients wait longer for uterine cancer testing, diagnosis

Study finds Black patients wait longer for uterine cancer testing, diagnosis

by Mallory Locklear,Yale UniversityCredit: Unsplash/CC0 Public DomainEarly diagnosis of uterine cancer is known to improve a patient's chances for survival, but previous research has found t
Oncology February 18,2024
First-in-class targeted microRNA therapy slows cancer tumor growth

First-in-class targeted microRNA therapy slows cancer tumor growth

by Purdue UniversityA new therapy targets cancer cells with a modified strand of micro-RNA that naturally blocks cell division. Credit: Second Bay Studios/Purdue UniversityA new cancer therapy de
Oncology February 18,2024
First-in-class targeted microRNA therapy slows cancer tumor growth

First-in-class targeted microRNA therapy slows cancer tumor growth

by Purdue UniversityA new therapy targets cancer cells with a modified strand of micro-RNA that naturally blocks cell division. Credit: Second Bay Studios/Purdue UniversityA new cancer therapy de
Oncology February 18,2024
Study identifies a potential therapeutic target for triple-negative breast cancer in Black patients

Study identifies a potential therapeutic target for triple-negative breast cancer in Black patients

by Adam Pope,University of Alabama at BirminghamProtein diversity due to alternative mRNA splicing or post-translational modifications (PTMs) plays a vital role in various cellular functions. Th
Oncology February 18,2024
Study identifies a potential therapeutic target for triple-negative breast cancer in Black patients

Study identifies a potential therapeutic target for triple-negative breast cancer in Black patients

by Adam Pope,University of Alabama at BirminghamProtein diversity due to alternative mRNA splicing or post-translational modifications (PTMs) plays a vital role in various cellular functions. Th
Oncology February 18,2024
A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

by Impact Journals LLCOptimization of circulating tumor cells (CTC) staining and validation of p300 activity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28477A new research paper wa
Oncology February 18,2024
A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

by Impact Journals LLCOptimization of circulating tumor cells (CTC) staining and validation of p300 activity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28477A new research paper wa
Oncology February 18,2024
Genetically engineered bacteria can detect cancer cells in a world-first experiment

Genetically engineered bacteria can detect cancer cells in a world-first experiment

by Dan Worthley,The ConversationCredit: AI-generated imageAs medical technology advances, many diseases could be detected, prevented and cured with cells, rather than pills.This branch of medici
Oncology February 18,2024
Genetically engineered bacteria can detect cancer cells in a world-first experiment

Genetically engineered bacteria can detect cancer cells in a world-first experiment

by Dan Worthley,The ConversationCredit: AI-generated imageAs medical technology advances, many diseases could be detected, prevented and cured with cells, rather than pills.This branch of medici
Oncology February 18,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com